Skip to main content
. 2013 Apr 26;66(1):14–20. doi: 10.5173/ceju.2013.01.art5

Table 1.

Predicted versus actual 1-year recurrence and progression rates

Recurrence group EORTC's recurrence prediction (score) No. of patients Observed 1-year recurrence proportion no. (%) Progression group EORTC's progression prediction (score) No. of patients Observed 1-year progression proportion no. (%)
Low 15% risk (0) 29 4 (13.7%) Low 0.2% risk (0) 37 1 (2.7%)
Intermediate 24% risk (1-4) 40 12 (30%) Intermediate 1% risk (2-6) 35 5 (14.3%)
Intermediate 38% risk (5-9) 20 6 (30%) Intermediate 5% risk (7-13) 16 4 (25%)
High 61% risk (10-17) 2 1 (50%) High 17% risk (14-23) 3 1 (33.3%)
Total 91 Total 91